Phosphorylation of IGF-1R and subsequent activation of downstream signalling cascades were also found to contribute to tamoxifen resistance and drive cell proliferation in breast cancer (Kruger et al., 2020). This evidence concerns the gene IGF1R and breast carcinoma.